WKN DE: A41188 / ISIN: US5787841007

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV		Knock-Outs
Historisch			Analysen

Kurse + Charts + Realtime
Kurs + Chart
Chart (groß)
Times + Sales
Chartvergleich
Börsenplätze
Realtime Push
Historisch

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Aktion
Portfolio
Watchlist

Maze Therapeutics Times and Sales (NAS)

Zeit	Kurs	Umsatz (Stk)
21:59:26	29,380	12
21:59:26	29,380	12
21:59:26	29,380	100
21:59:23	29,390	10
21:59:23	29,390	4
21:59:22	29,390	70
21:59:22	29,380	63
21:59:22	29,380	12
21:59:22	29,380	12
21:59:22	29,360	10
21:59:22	29,360	15
21:59:22	29,380	56
21:59:22	29,380	4
21:59:22	29,380	6
21:59:22	29,400	11
21:59:22	29,400	6
21:59:22	29,400	35
21:59:22	29,400	5
21:59:22	29,400	101
21:59:22	29,400	41
21:59:22	29,400	2
21:59:22	29,400	37
21:59:22	29,400	14
21:59:22	29,400	49
21:59:22	29,400	15
21:59:22	29,400	100
21:59:22	29,400	5
21:59:22	29,400	15
21:59:22	29,400	1
21:59:22	29,400	7
21:59:22	29,400	7
21:59:22	29,400	1
21:59:19	29,435	9
21:59:18	29,435	1
21:59:18	29,435	10

Kursrückgang	Kursanstieg	keine Kursänderung
(Balkenlänge beschreibt das Umsatzvolumen)

Analysen zu Maze Therapeutics Inc Registered Shs

Weitere Meldungen

13:55		ICF vs. HAUZ: Should You Bet on U.S. REITs or International Real Estate?
13:53		UnitedHealth Stock in the Spotlight Ahead of Q2 Earnings Thursday
13:48		SpaceX Engineers Raise $115 Million to Make Construction Faster, Cheaper and Safer After Learning At ‘a Crazy Pace’ Under Elon Musk
13:47		Prediction: Sandisk Stock Is Going to Hit $3,000 by the End of 2026. Here's the Math
13:43		The Fed Has Missed Its 2% Inflation Target for 64 Straight Months— And One Market Strategist Says It Has 'Lost All Credibility'
13:43		Morgan Stanley wealth management boosted by SpaceX millionaires
13:40		SpaceX bond yields rocket towards junk
13:39		What's Going on With IBM Stock Wednesday?
13:38		This Check Point Software Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
13:36		Netflix earnings are coming. Here’s what’s needed to prop up the tumbling stock.
13:30		AI Capex Crosses $1 Trillion Next Year. Here Are 2 Industrial Stocks That Will Benefit
13:24		What's Going on With AMD Stock Wednesday?
13:19		Here's How Many Shares of Costco Stock You'd Need for $1,000 in Yearly Dividends
13:17		Chamath Palihapitiya Once Donated $750,000 to Spite Trump— Now He's Calling Him a 'Fantastic' President and Blaming The Media: 'I Took the Time to Learn...'
13:17		Looking for International Diversification? Here's How Vanguard's VXUS and VEA ETFs Compare in 2026.
13:15		Warren Buffett's Hand-Picked Successor, Greg Abel, Revamped Berkshire Hathaway's Portfolio. Should You Buy the Only Berkshire Dividend Stock Left That Yields Over 6%?
13:13		BlackRock has best-ever start to a year as investment flows double and profits surge
13:09		USA: Regierung erlässt KI-Executive-Order „Gold Eagle“
13:05		SK Hynix Controls More Than Half the HBM Market Nvidia Depends On
13:04		One answer to EU strategic autonomy is orbiting overhead
13:00		Pentair Stock Plunges as Pool Destocking Forces Deep 2026 Guidance Cut
13:00		The energy transition’s last mile
13:00		Industrials could be the next big bottleneck trade. Here are some stocks that could benefit.
13:00		Is SpaceX Planning to Make a Smartphone to Rival the iPhone?
12:59		This Veracyte Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
12:56		ComfortDelGro appoints Yap Chee Kean to newly created group COO role
12:56		ComfortDelGro appoints Yap Chee Khean to newly created group COO role
12:56		Truist Financial Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
12:54		Luxury stocks rally on Richemont sales beat — but the sector still needs China, says analyst
12:50		Billionaire Drahi’s Altice International accused of defaulting on €2bn of debt
12:50		Billionaire Drahi’s Altice International accused of defaulting on €2bn of debt
12:47		U.S. Official Says NVIDIA H200 Shipments to China Are 'Trivial'
12:45		Singapore shares rise as STI hits record close above 5,500
12:45		EU set to fine Google hundreds of millions of euros
12:45		Amazon Is Throwing Billions at Warehouse Robotics: What That Means for Symbotic's Stock.
12:39		Elon Musk Faces Possible Election Bribery Charges in Wisconsin Over $1 Million Voter Giveaway
12:39		Chuck Schumer Slams Trump's Iran War Strategy, Says Trump Has 'No Plan and No Exit Strategy' as Military Campaign Enters Day 136
12:37		New Research Shows Billion-Dollar Data Centers Enrich Metro Areas While Rural Communities Host the Facilities and Pay Higher Electricity Bills
12:32		Trump’s Golden Dome Push Gets $1.75 Billion Boost, Space Force Orders 36 Missile-Tracking Satellites From Sierra Space and L3Harris
12:32		What's Going on With Micron Technology Stock Wednesday?
12:31		CoreWeave Weighs Derivatives to Protect Against Falling Chip Prices: Report
12:30		6 Cryptocurrencies I'm Watching Like a Hawk in July
12:29		JF SmartInvest Turns To AI To Serve High-Net-Worth Clients Seeking Investment Advice
12:26		United Airlines Touts More Legroom, Replaces Select Middle Seats With Shared Tables on New Airbus A321XLR
12:25		3 Vanguard ETFs Poised to Outperform as the Market Shifts Beyond Big Tech
12:25		Smart Glasses: Neue EU-Akkuvorgaben kommen Meta entgegen
12:24		AI Chip Spending Is Projected to Hit $1.6 Trillion by 2030. Here Are the Stocks Positioned to Capture Much of It.
12:20		Aehr CEO Says AI Will Be Bigger Piece of Business as Orders Keep Rolling In
12:19		Is The Rise Of AI Fatigue Beginning To Drive S&P 500 Lower?
12:17		Fraunhofer eröffnet drei Humanoid Robots Experience Labs in Deutschland

Erste Seite Zurück | ... | 2 | 3 | 4 | 5 | Weiter

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Weitere Aktien: Aichi Electric Denta Water and Infra Solutions Cloudastructur a ca markets ZK International Group

Kontakt - Impressum - Werbung - Barrierefreiheit

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2026 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 80% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	15.07.2026 22:55
Kaufwert:	EUR
	Hinzufügen Speichern

Maze Therapeutics Aktie

WKN DE: A41188 / ISIN: US5787841007

Maze Therapeutics Times and Sales (NAS)

Analysen zu Maze Therapeutics Inc Registered Shs

Weitere Meldungen